Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial
Christian Morath, Anita Schmitt, Michael Schmitt, Lei Wang, Christian Kleist, Gerhard Opelz, Caner Süsal, T. Hien Tran, Sabine Scherer, Vedat Schwenger, Stephan Kemmner, Michael Fischereder, Manfred Stangl, Ingeborg A. Hauser, Claudia Sommerer, Christian Nusshag, Florian Kälble, Claudius Speer, Louise Benning, Christian BischofsSandra Sauer, Maria Luisa Schubert, Alexander Kunz, Angela Hückelhoven-Krauss, Brigitte Neuber, Arianeb Mehrabi, Constantin Schwab, Rüdiger Waldherr, Anja Sander, Christopher Büsch, David Czock, Georg A. Böhmig, Jochen Reiser, Axel Roers, Carsten Müller-Tidow, Peter Terness, Martin Zeier, Volker Daniel, Matthias Schaier
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial'. Together they form a unique fingerprint.